Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.6800
-0.0665 (-8.91%)
May 9, 2025, 1:57 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotherapeutics
570.00K
Log In
Log In
Log In
Log In
Biotherapeutics Growth
107.27%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
570.00K
Log In
Log In
Log In
Log In
United States Growth
107.27%
Log In
Log In
Log In
Log In